Efficacy and Safety of Secukinumab in Patients with Spondyloarthritis and Enthesitis at the Achilles Tendon: 52-weeks Results from a Randomized, Placebo-controlled Phase 3b Trial

被引：0

作者：

Behrens, Frank ^{[1
,2
]}

Sewerin, Philipp ^{[3
,4
]}

De Miguel, Eugenio ^{[5
]}

Patel, Yusuf ^{[6
]}

Batalov, Anastas ^{[7
]}

Dokoupilova, Eva ^{[8
,9
]}

Kleinmond, Christine ^{[10
]}

Pournara, Effie ^{[11
]}

Shekhawat, Ankita ^{[12
]}

Jentzsch, Claudia ^{[13
]}

Wiedon, Annette ^{[14
]}

Baraliakos, Xenofon ^{[15
]}

机构：

[1] Goethe Univ, CIRI Rheumatol, Frankfurt, Germany

[2] Goethe Univ, Fraunhofer TMP, Frankfurt, Germany

[3] Univ Hosp Dusseldorf, Dept Rheumatol, Dusseldorf, Germany

[4] Univ Hosp Dusseldorf, Hiller Res Unit, Dusseldorf, Germany

[5] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain

[6] Hull Univ Teaching Hosp, Kingston Upon Hull, East Yorkshire, England

[7] Med Univ Plovdiv, Univ Hosp Kaspela, Plovdiv, Bulgaria

[8] Med Plus Sro, Uherske Hradiste, Czech Republic

[9] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Pharmaceut, Uherske Hradiste, Czech Republic

[10] ClinProject GmbH, Eurasburg, Germany

[11] Novartis Pharma AG, Basel, Switzerland

[12] Novartis Healthcare Private Ltd, Hyderabad, Telangana, India

[13] Novartis Pharma GmbH, Nurnberg, Germany

[14] Novartis Pharma GmbH, Nurnberg, Germany

[15] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0882

引用

页数：3

共 50 条

[1] Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial
Behrens, Frank
Sewerin, Philipp
de Miguel, Eugenio
Patel, Yusuf
Batalov, Anastas
Dokoupilova, Eva
Kleinmond, Christine
Pournara, Effie
Shekhawat, Ankita
Jentzsch, Claudia
Wiedon, Annette
Baraliakos, Xenofon
RHEUMATOLOGY, 2022, 61 (07) : 2856 - 2866
[2] Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study
Deodhar, Atul
Supronik, Jerzy
Kivitz, Alan
Valenzuela, Guillermo
Kapur, Karen
Rohrer, Susanne
Dokoupilova, Eva
Richards, Hanno B.
Pavelka, Karel
ARTHRITIS & RHEUMATOLOGY, 2024,
[3] ARTHRITIS: PRIMARY RESULTS THROUGH 52-WEEKS FROM A PHASE-3 RANDOMIZED PLACEBO-CONTROLLED STUDY (FUTURE 4)
Kivitz, A.
Nash, P.
Tahir, H.
Everding, A.
Pellet, P.
Widmer, A.
Pricop, L.
Abrams, K.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S1 - S2
[4] Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial
Elewski, B. E.
Baker, C. S.
Crowley, J. J.
Poulin, Y.
Okun, M. M.
Calimlim, B.
Geng, Z.
Servin, O. Reyes
Rich, P. A.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (11) : 2168 - 2178
[5] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Nash, Peter
Mease, Philip J.
McInnes, Iain B.
Rahman, Proton
Ritchlin, Christopher T.
Blanco, Ricardo
Dokoupilova, Eva
Andersson, Mats
Kajekar, Radhika
Mpofu, Shephard
Pricop, Luminita
ARTHRITIS RESEARCH & THERAPY, 2018, 20
[6] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Peter Nash
Philip J. Mease
Iain B. McInnes
Proton Rahman
Christopher T. Ritchlin
Ricardo Blanco
Eva Dokoupilova
Mats Andersson
Radhika Kajekar
Shephard Mpofu
Luminita Pricop
Arthritis Research & Therapy, 20
[7] Achilles Tendon Enthesitis and Disease Burden in Psoriatic Arthritis and Axial Spondyloarthritis: Baseline Results from a Randomized Controlled Trial
Behrens, Frank
Sewerin, Philipp
de Miguel, Eugenio
Patel, Yusuf
Batalov, Anastas
Dokoupilova, Eva
Kleinmond, Christine
Pournara, Effie
Shekhawat, Ankita
Jentzsch, Claudia
Wiedon, Annette
Baraliakos, Xenofon
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[8] Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial
Sofen, Howard L.
Gebauer, Kurt
Spelman, Lynda
Yamauchi, Paul S.
Yao, Siu-Long
Nishandar, Tushar
Kopeloff, Iris
Crane, Michael
Gogineni, Ranga
Kothekar, Mudgal
Bagel, Jerry
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (04) : 816 - 824
[9] Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study
Kivitz, Alan
Sedova, Liliana
Churchill, Melvin
Kotha, Roshan
Singhal, Atul
Torres, Alexander
Valenzuela, Guillermo
Whelan, Sarah
Dumortier, Thomas
Zhu, Xuan
Martin, Ruvie
Pricop, Luminita
ARTHRITIS & RHEUMATOLOGY, 2024,
[10] Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
Elewski, Boni E.
Okun, Martin M.
Papp, Kim
Baker, Christopher S.
Crowley, Jeffrey J.
Guillet, Gerard
Sundaram, Murali
Poulin, Yves
Gu, Yihua
Geng, Ziqian
Williams, David A.
Rich, Phoebe A.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 90 - +

← 1 2 3 4 5 →